MELANIE GREENWAY: Open Payments
NPI 1598195604 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 94 payments from 19 companies in 2025. Trend: 2023 $2,126 · 2024 $1,685 · 2025 $1,732
Food & beverage: $1,732
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $366 |
| ABBVIE INC. | 20 | $231 |
| Novo Nordisk Inc | 9 | $192 |
| Astellas Pharma US Inc | 6 | $174 |
| Amgen Inc. | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Lilly USA, LLC | 3 | $61 |
| Lundbeck LLC | 2 | $57 |
Products named: PREVNAR 20, Veozah, VRAYLAR, BREZTRI, OTEZLA, NURTEC ODT, Ozempic, JARDIANCE.
Industry payments across MD — which companies pay providers there.
